Shilpa Medicare Limited — Important, 10-07-2025: General Updates

Shilpa Medicare’s Unit VI facility in Bengaluru has received GMP certification from Saudi Arabia’s SFDA after a full inspection with zero observations. This site manufactures oral films and transdermal patches, supplying markets including the US, Australia, and emerging countries. The facility is also approved by the European Medicines Agency, enhancing Shilpa’s global manufacturing credentials and supporting its contract development and manufacturing services, especially in oncology and biologics.